Key result
Multidisciplinary surgical treatment of clear-cell renal cell carcinoma with inferior vena cava tumor thrombus level III and IV resulted in a 29-month overall survival of 69%.
Why the study?
Level III and IV inferior vena cava tumor thrombi in non-metastatic, stage T3 clear-cell renal cell cancer present a clinical challenge requiring cardiopulmonary bypass, hypothermic arrest, and a multidisciplinary surgical approach.
Does multidisciplinary surgical treatment improve outcomes in patients with non-metastatic clear-cell renal cell carcinoma with inferior vena cava tumor thrombus level III and IV?
Observational (n=12)
No
Does multidisciplinary surgical treatment improve outcomes in patients with non-metastatic clear-cell renal cell carcinoma with inferior vena cava tumor thrombus level III and IV?
Aggressive multidisciplinary surgical treatment utilizing cardiopulmonary bypass and hypothermic arrest is feasible and yields a 69% 29-month overall survival in patients with clear-cell renal cell carcinoma and level III/IV IVC tumor thrombus.
Small series of complex IVC thrombus resections adds perioperative data; leaves open standardized protocols for T3 RCC.
Patients with non-metastatic, stage T3 clear-cell renal cell cancer present a clinical challenge for urologists. The extent of tumor thrombus in inferior vena cava is the primary determinant of surgical procedure complexity. Level III and IV thrombi require the use of cardiopulmonary bypass and hypothermic arrest. Careful preoperative planning and a multidisciplinary approach are mandatory. In this paper, we report outcomes of 12 patients who were surgically treated in our center. The 29 months overall survival for all patients was 69%, while three patients died during follow-up. Of nine surviving patients, six are currently disease-free, whereas three had disease progression. Our study showed that carefully selected patients with clear-cell renal cell carcinoma with inferior vena cava tumor thrombus level III and IV could be successfully treated with an aggressive surgical approach.
No takes yet. Share an insight, caveat, or question.
Hudolin et al. (2020) conducted an observational in Clear-cell renal cell carcinoma with inferior vena cava tumor thrombus level III and IV (n=12). Multidisciplinary surgical treatment was evaluated on Overall survival. Multidisciplinary surgical treatment of clear-cell renal cell carcinoma with inferior vena cava tumor thrombus level III and IV resulted in a 29-month overall survival of 69%.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: